ConductScience.org, home

Paper9971817

Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Mörner A and 8 others. J Virol, 1999. Cited by 289 papers, by iCite.

Cite this record

ConductScience Library. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. Papers, record 9971817. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9971817

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
PubMed
Journal
J Virol
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
289
iCite
Relative citation ratio, by iCite
6.09
iCite
Revised in PubMed
2025-05-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mörner AA
2Björndal AA
3Albert JJ
4Kewalramani VNV N
5Littman DRD R
6Inoue RR
7Thorstensson RR
8Fenyö EME M
9Björling EE

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV-2Major topic
Receptors, CCR5Major topic
Receptors, G-Protein-CoupledMajor topic
Receptors, HIVMajor topic
Receptors, VirusMajor topic
Humans
RNA, Messenger
Receptors, CXCR4
Receptors, CXCR6
Receptors, Chemokine
Receptors, Cytokine
Receptors, Peptide
Tumor Cells, Cultured
Virulence

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11347054Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.J Infect Dis1992https://conductscience.org/library/papers/1347054PubMed
21501283Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein.J Virol1992https://conductscience.org/library/papers/1501283PubMed
31673040Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.Virology1991https://conductscience.org/library/papers/1673040PubMed
41706769A capture enzyme immunoassay for detection of HIV-2/SIV antigen.J Acquir Immune Defic Syndr (1988)1991https://conductscience.org/library/papers/1706769PubMed
51905842Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.Science1991https://conductscience.org/library/papers/1905842PubMed
62190603Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency.AIDS1990https://conductscience.org/library/papers/2190603PubMed
72425430Isolation of a new human retrovirus from West African patients with AIDS.Science1986https://conductscience.org/library/papers/2425430PubMed
82564945Replicative and cytopathic characteristics of HIV-2 and severity of infection.Lancet1989https://conductscience.org/library/papers/2564945PubMed
93040053A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.AIDS Res Hum Retroviruses1987https://conductscience.org/library/papers/3040053PubMed
107909009Slower heterosexual spread of HIV-2 than HIV-1.Lancet1994https://conductscience.org/library/papers/7909009PubMed
117915856Reduced rate of disease development after HIV-2 infection as compared to HIV-1.Science1994https://conductscience.org/library/papers/7915856PubMed
127962552Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.J Clin Invest1994https://conductscience.org/library/papers/7962552PubMed
138356453Genotypic and phenotypic characterization of HIV-1 patients with primary infection.Science1993https://conductscience.org/library/papers/8356453PubMed
148438591Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.Virology1993https://conductscience.org/library/papers/8438591PubMed
158525373Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.Science1995https://conductscience.org/library/papers/8525373PubMed
168629022HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.Science1996https://conductscience.org/library/papers/8629022PubMed
178649511Identification of a major co-receptor for primary isolates of HIV-1.Nature1996https://conductscience.org/library/papers/8649511PubMed
188649512HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.Nature1996https://conductscience.org/library/papers/8649512PubMed
198658171CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.Science1996https://conductscience.org/library/papers/8658171PubMed
208707053FACS-optimized mutants of the green fluorescent protein (GFP).Gene1996https://conductscience.org/library/papers/8707053PubMed

See all 48 referencesDownload CSV of references

Cited by180

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 289 citations.

PMIDTitleJournalYearIn PapersSource
41987899Galectin-8 binds HIV envelope glycoproteins with high affinity and promotes viral infectivity.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/41987899PubMed
41886485High-throughput high content quantification of HIV-1 viral infectious output.PLoS One2026https://conductscience.org/library/papers/41886485PubMed
40507836Macrophage-Derived Factors with the Potential to Contribute to the Pathogenicity of HIV-1 and HIV-2: Roles of M-CSF and CXCL7.Int J Mol Sci2025https://conductscience.org/library/papers/40507836PubMed
39998123Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging.J Virol2025https://conductscience.org/library/papers/39998123PubMed
39673132In vivo evolution of env in SHIV-AD8EO-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig.Mol Ther2025https://conductscience.org/library/papers/39673132PubMed
39459974The HIV-1 vpr R77Q Mutant Induces Apoptosis, G2 Cell Cycle Arrest, and Lower Production of Pro-Inflammatory Cytokines in Human CD4+ T Cells.Viruses2024https://conductscience.org/library/papers/39459974PubMed
39039298Targeting monocytic Occludin impairs transendothelial migration and HIV neuroinvasion.EMBO Rep2024https://conductscience.org/library/papers/39039298PubMed
38876144Studying Retroviral Life Cycles Using Visible Viruses and Live Cell Imaging.Annu Rev Virol2024https://conductscience.org/library/papers/38876144PubMed
38500818HIV-2 mediated effects on target and bystander cells induce plasma proteome remodeling.iScience2024https://conductscience.org/library/papers/38500818PubMed
38385695Distinct genetic clusters in HIV-1 CRF01_AE-infected patients induced variable degrees of CD4+ T-cell loss.mBio2024https://conductscience.org/library/papers/38385695PubMed
38241476HIV-1 Capsid Uncoating Is a Multistep Process That Proceeds through Defect Formation Followed by Disassembly of the Capsid Lattice.ACS Nano2024https://conductscience.org/library/papers/38241476PubMed
37328105SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection.J Biol Chem2023https://conductscience.org/library/papers/37328105PubMed
37243118Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+ T Lymphocytes.Viruses2023https://conductscience.org/library/papers/37243118PubMed
36866043Single-cell RNA-seq analysis reveals dual sensing of HIV-1 in blood Axl+ dendritic cells.iScience2023https://conductscience.org/library/papers/36866043PubMed
36366545Intra-Patient Evolution of HIV-2 Molecular Properties.Viruses2022https://conductscience.org/library/papers/36366545PubMed
36289397Evasion of cGAS and TRIM5 defines pandemic HIV.Nat Microbiol2022https://conductscience.org/library/papers/36289397PubMed
35840493Cell-to-cell transmission of HIV-1 from provirus-activated cells to resting naïve and memory human primary CD4 T cells is highly efficient and requires CD4 and F-actin but not chemokine receptors.J Med Virol2022https://conductscience.org/library/papers/35840493PubMed
35563157HIV-2 Neutralization Sensitivity in Relation to Co-Receptor Entry Pathways and Env Motifs.Int J Mol Sci2022https://conductscience.org/library/papers/35563157PubMed
35412135Endogenous Peptide Inhibitors of HIV Entry.Adv Exp Med Biol2022https://conductscience.org/library/papers/35412135PubMed
34985666Experimental Models to Study HIV Latency Reversal from Male Genital Myeloid Cells.Methods Mol Biol2022https://conductscience.org/library/papers/34985666PubMed

See all 180 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9971817

GET https://conductscience.org/api/papers/v1/9971817/references?page=2